Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 May;15(5):1496-1512.
doi: 10.1007/s13346-024-01749-w. Epub 2024 Nov 26.

Nanoparticles in the battle against Candida auris biofilms: current advances and future prospects

Bahgat Fayed  1
Affiliations
Review

Nanoparticles in the battle against Candida auris biofilms: current advances and future prospects

Bahgat Fayed. Drug Deliv Transl Res. 2025 May.

Abstract

Candida auris has emerged as a significant global health threat due to its multidrug resistance and ability to form robust biofilms, particularly on medical devices and hospital surfaces. Biofilms protect C. auris from antifungal treatments and the host immune response, making infections persistent and difficult to control. This review explores the potential of nanoparticles to overcome the limitations of traditional antifungal therapies in combating C. auris biofilms. Nanoparticles, with their unique physicochemical properties, offer promising strategies to penetrate biofilm matrices, deliver antifungal agents, and disrupt biofilm structure. Various types of nanoparticles, including metallic, polymeric, lipid-based, and cyclodextrin-based, demonstrate enhanced biofilm penetration and antifungal activity. Their ability to generate reactive oxygen species, disrupt cell adhesion, and release antifungals in a controlled manner makes them ideal candidates for biofilm-targeted therapies. This review presents the current advancements in nanoparticle-based solutions, emphasizing the need for further research into their mechanisms of action, safety, and clinical application. By addressing the challenge of C. auris biofilms specifically, this review provides a critical synthesis of existing knowledge and identifies future directions for developing effective antifungal therapies using nanotechnology.

Keywords: Antifungal therapy; Biofilm; Multidrug resistance; Nanoparticles.

PubMed Disclaimer

Conflict of interest statement

Declarations. Ethics approval and consent to participate: This article does not contain any studies with human participants or animals performed by any of the authors. Consent for publication: Not applicable. Competing interests: The authors have no relevant financial or nonfinancial interests to disclose.

Figures

Fig. 1
Fig. 1
Mechanism of nanoparticles against C. auris biofilm. (A) Nanoparticles enhance antifungal penetration, (B) Nanoparticles disrupt C. auris biofilm structure by direct interacting with the biofilm matrix, (C) Nanoparticles release intracellular ROS, (D) Nanoparticles prevent C. auris adhesion and consequently biofilm formation
Fig. 2
Fig. 2
Challenges and considerations in using nanoparticles against Candida auris biofilms
Fig. 3
Fig. 3
Future prospective for the nanoparticles application against C. auris biofilm. (A) nanoparticles functionalizing them with ligand target mannoprotein, (B) pH-responsive nanoparticles that release antifungal drug in the acidic environment of the C. auris biofilm, (C) nanoparticles that co-deliver multiple antifungal drugs, (D) lipid-polymer hybrid nanoparticles, (E) nanoparticles modulate immune activity against C. auris biofilm
See this image and copyright information in PMC

References

    1. Satoh K, Makimura K, Hasumi Y, Nishiyama Y, Uchida K, Yamaguchi H. Candida Auris sp. nov., a novel ascomycetous yeast isolated from the external ear canal of an inpatient in a Japanese hospital. Microbiol Immunol. 2009;53(1):41–4. - PubMed
    1. Fayed B, Lazreg IK, AlHumaidi RB, Qasem MA, Alajmy BMGN, Bojbarah FM, et al. Intra-clade heterogeneity in Candida Auris: risk of management. Curr Microbiol. 2023;80(9):295. - PubMed
    1. Ismail SA, Fayed B, Abdelhameed RM, Hassan AA. Chitinase-functionalized UiO-66 framework nanoparticles active against multidrug-resistant Candida Auris. BMC Microbiol. 2024;24(1):269. - PMC - PubMed
    1. Pallotta F, Viale P, Barchiesi F. Candida Auris: the new fungal threat. Infez Med. 2023;31(3):323–8. - PMC - PubMed
    1. Fayed B, Shakartalla SB, Sabbah H, Dalle H, Tannira M, Senok A, et al. Transcriptome Analysis of Human Dermal Cells Infected with Candida Auris Identified Unique Pathogenesis/Defensive mechanisms particularly ferroptosis. Mycopathologia. 2024;189(4):65. - PubMed

MeSH terms

Substances

LinkOut - more resources